Sun Pharma Advanced Research Company (SPARC) today posted a net loss of Rs 11.2 crore for the first quarter ended June 30, 2011.
The company had posted a net profit of Rs 48 lakh in the same period previous fiscal, SPARC said in a statement.
The company's total income stood at Rs 10 crore in the June quarter, while the same was Rs 15 crore in the corresponding period of last financial year.
SPARC was demerged from Sun Pharma as a pharma research and drug discovery company in 2007.
Shares of SPARC were trading at Rs 81.95 on the Bombay Stock Exchange in late afternoon trade, down 3.64% from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app